SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-127579
Filing Date
2022-04-28
Accepted
2022-04-28 16:14:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d354250ddefa14a.htm DEFA14A 28478
2 GRAPHIC g354250g00c36.jpg GRAPHIC 64793
3 GRAPHIC g354250g01g02.jpg GRAPHIC 107284
4 GRAPHIC g354250g79p35.jpg GRAPHIC 27836
  Complete submission text file 0001193125-22-127579.txt   294076
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37539 | Film No.: 22866720
SIC: 2834 Pharmaceutical Preparations